The lenacapavir HIV Prevention Injection rollout begins in SA, but activists warn that limited supply from Gilead could blunt the impact.
Lenacapavir HIV Prevention Injection: SA Rollout Faces Heat
Original Article by Tamar Kahn | Business Day | 5 June 2026
The lenacapavir HIV Prevention Injection rollout begins in SA, but activists warn that limited supply from Gilead could blunt the impact.
More Posts
Compounded semaglutide appeal dismissed
A court has upheld restrictions on compounded semaglutide at iDexis while regulatory investigations continue.
Read more...
WHO’s Africa Chief Urges Action, Not Talk, on Primary Healthcare
WHO Africa director Mohamed Janabi urged governments to finance primary healthcare and pursue health sovereignty.
Read more...
Unpaid specialist training strains SA doctors
Unpaid specialist training is growing in South Africa as scarce funded posts leave doctors working without salaries.
Read more...